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OBJECTIVES: To correlate the importance of the ankle-brachial index in terms of cardiovascular morbimortality
and the extent of coronary arterial disease amongst elderly patients without clinical manifestations of lower
limb peripheral arterial disease.
METHODS:We analyzed prospective data from 100 patients over 65 years of age with coronary arterial disease,
as confirmed by coronary angiography, and with over 70% stenosis of at least one sub-epicardial coronary
artery. We measured the ankle-brachial index immediately after coronary angiography, and a value of ,0.9
was used to diagnose peripheral arterial disease.
RESULTS: The patients’ average age was 77.4 years. The most prevalent risk factor was hypertension (96%), and
the median late follow-up appointment was 28.9 months. The ankle-brachial index was ,0.9 in 47% of the
patients, and a low index was more prevalent in patients with multiarterial coronary disease compared to
patients with uniarterial disease in the same group. Using a bivariate analysis, only an ankle-brachial index of
,0.9 was a strong predictive factor for cardiovascular events, thereby increasing all-cause deaths and fatal and
non-fatal acute myocardial infarctions two- to three-fold.
CONCLUSION: In elderly patients with documented coronary disease, a low ankle-brachial index (,0.9) was
associated with the severity and extent of coronary arterial disease, and in late follow-up appointments, a low
index was correlated with an increase in the occurrence of major cardiovascular events.
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& INTRODUCTION
Peripheral Arterial Disease of the lower limbs (PAD) is a
prevalent form of atherosclerotic disease. It has been
estimated that in both North America and Europe, PAD
affects approximately 27 million people, representing 16%
of the North American population over 55 years of age (1).
Longevity is a risk factor for the development of PAD
Data from the National Health and Nutrition Examination
Survey (NHANES) indicate that PAD prevalence among
people over 70 years of age is three times higher compared
to patients 40–70 years of age (14.5% and 4.3%, respectively)
(2).
The coexistence of PAD with Coronary Arterial Disease
(CAD) and cerebrovascular disease (CVD) is well known.
The REACH trial, which involved elderly patients with
CAD, CVD and symptomatic or asymptomatic PAD with
three or more atherothrombotic risk factors, demonstrated
that 70% of patients with PAD have atherosclerotic disease
in other vascular beds (3). According to Belch et al. (1),
individuals with low ankle-brachial indices (ABIs) have
twice the chance of presenting CAD compared to subjects
with normal ABIs and have increased risks of fatal and
nonfatal myocardial infarctions, stroke and cardiovascular
mortality as well as increased overall mortality.
The ABI is a simple, non-invasive method used to
diagnose PAD. Compared to lower limb arterial angiogra-
phy, an ABI ,0.9 has been shown to have a sensitivity of
90–97% and a specificity of 98–100% for detecting stenosis
that affects the lumen in more than 50% of one or more leg
arteries (4). Some studies have shown an association
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between the extent of CAD and PAD detected by ABI,
regardless of the presence of symptoms (5), and it is known
that the association between PAD and CAD increases all-
cause mortality and the cardiovascular risk of these patients
two- to three-fold (6). Additionally, in some cases, isolated
PAD has been responsible for increased mortality compared
to patients with isolated CAD or CVD (3).
Data from patients with suspected CAD who have been
referred for coronary angiography indicated that PAD
prevalence is high when evaluated by ABI (6,7).
Therefore, although we have examined a high-risk group
of patients, elderly patients with documented CAD and no
PAD manifestations, this study aims to evaluate the impact
of ABI as a marker of cardiovascular events in these patients
and to evaluate the relationship between ABI and the extent
of CAD as documented by coronary angiography.
& METHODS
During the study period, 425 coronary angiographies
were performed in patients older than 65 years. Of these
patients, 109 were evaluated, and 100 patients met the
inclusion criteria. Therefore, we conducted a prospective
observational cohort study of 100 consecutive patients aged
$65 years who were asymptomatic for peripheral vascular
disease and documented CAD by coronary angiography
and who, immediately after hemodynamic investigation,
were submitted to ABI determination and were followed for
a mean period of 28.9¡6.6 months by either medical care or
telephonic contact. Angiographic inclusion criteria were
defined as a stenosis that was $70% of the epicardial
coronary artery in at least one vessel and/or greater than
50% of the left coronary branch. The extent of CAD was
evaluated by the number of vessels involved: uniarterial
when there was an isolated lesion in one coronary artery
and multiarterial when evidence of CAD was present in two
or more vessels. Hypertension was defined according to the
criteria of the IV Brazilian Guidelines on Hypertension (a
systolic blood pressure greater than or equal to 140 mmHg
and a diastolic blood pressure greater than or equal to
90 mmHg with an associated cardiovascular risk factor)
and/or use of antihypertensive medication (8). Diabetes
mellitus was diagnosed using the criteria of the American
Diabetes Association: two fasting glucose measurements
greater than or equal to 126 mg/dl, an oral glucose
tolerance test with a post-load value within the 2 hours
that was greater than or equal to 200 mg/dl or a casual
plasma glucose greater than or equal to 200 mg/dl (9).
Dyslipidemia was defined as having plasma cholesterol
levels greater than 240 mg/dl, low-density lipoprotein
(LDL) cholesterol levels between 160 and 189 mg/dl and
high-density lipoprotein (HDL) cholesterol levels ,40 mg/
dl, according to the III Brazilian Guidelines on Dyslipidemia
and Atherosclerosis Prevention (10). Smoking was assessed
(current smoker or former) regardless of smoking history.
We considered the following items as major cardiovascular
events (MACE) to be prospectively studied: all-cause
mortality, fatal and non-fatal myocardial infarction (MI)
and stroke (transient or not).
All patients included in the study were outpatients who
were cared for in the Cardiogeriatrics Center at UNIFESP,
and the patients who agreed to take part in the study signed
an informed consent document. This study was approved
by the ethics and research committee of the Universidade
Federal de Sa˜o Paulo in accordance with the 1975 Helsinki
Declaration and was registered as CEP 1254/09.
We excluded elderly patients with a clinical history of
intermittent claudication, patients who had no significant
coronary atherosclerotic disease after cardiac catheterization
angiography, patients with an ABI $1.3 (non-compressible
arteries), patients with decompensated heart failure and/or
significant edema in their lower limbs, patients with
amputation and patients who refused to participate in the
study (11–13). The same physician (EDEP) performed all of
the clinical evaluations and ABI measurements; at the
inclusion of patients in the study, the physician did not
know the specific results of the coronary angiography and
the extent of coronary disease in each patient. However, the
physician did know that all of the patients would have
significant coronary disease.
Ankle-brachial index measurements
The ABI was measured using a portable vascular
Doppler scanning MEDPEJH (Sa˜o Paulo, Brazil) 10 Mhz
DV 2001 model and a BICH aneroid sphygmomanometer
(Sa˜o Paulo, Brazil) with appropriate cuff inflators for
brachial circumference, in accordance with international
standards (11).
During physical examination, the right arm circumference
was measured at the mid-point between the acromion and
the olecranon, and an appropriate cuff was selected. After a
least a 5-minute rest, the systolic pressures of the upper
(brachial) and lower (tibial posterior and dorsalis pedis)
limbs were measured in the supine position, initially taking
measures of the right superior member and, in sequence, the
left superior member, left inferior member and right inferior
member. The ABI of each inferior member was calculated
by dividing the highest systolic pressure at the ankles by the
highest systolic pressure of the upper arms. The lowest
value obtained was validated for analysis, and according to
the ABI value, PAD was classified as: severe (#0.5),
moderate (0.51–0.7), mild (0.71–0.9), and without PAD
(greater than or equal to 0.9). A pathological ABI was
considered to be a value ,0.9 (11,12).
Patients with an ABI of 1.3 or more (noncompressible
arteries) (13), an acute decompensated heart failure and/or
significant lower limb edema and an inferior member
amputation as well as those who refused to participate in
the study were not analyzed.
Statistical analysis and descriptive statistics
Quantitative data were described as the means and
standard deviations (SD). The cutoff for the ABI was ,0.9
for PAD diagnosis, taking into consideration values in the
literature as references (11,12). Taking into account the
characteristics of our sample, we assumed that we would
have a 6% yearly event rate in patients with ABIs,0.9 and a
1% event rate in patients with normal ABIs.
ABI analysis
We evaluated possible ABI predictors (as a dichotomized
variable) with bivariate analysis using the chi-square test or
Fisher test.
The continuous variable (age) in relation to ABI was
evaluated using Student’s t-test for independent samples
and the Kolmogorov-Smirnov test when necessary to
determine whether the age followed a normal distribution.
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The strength of association was measured using the Relative
Risk (RR) with a 95% confidence interval (CI).
For the bivariate analysis, we considered a 10% signifi-
cance level to be significant if more than one isolated tested
variable was identified. A Poisson Regression model with
an estimated RR was used to evaluate the combined
occurrence of highest systolic blood pressure as a contin-
uous variable and multiarterial disease events.
Analysis of clinical events
We evaluated possible clinical event predictors (deaths,
acute myocardial infarction [AMI], hospital admissions,
MACE) with a bivariate analysis using the chi-square test or
the Fisher Test.
The continuous variable (age) was evaluated in relation to
the ABI using Student’s t-test for independent samples and
the Kolmogorov-Smirnov test when necessary.
Time elapsed between the PAD diagnosis and occurrence
of MACE, and AMI was estimated calculating the last
patient contact date minus the PAD diagnosis date for
patients with no events. For patients with events, we
determined the time considering the event occurrence date
and the PAD diagnosis date. When the event date was
uncertain, we considered the last patient contact date as the
event date.
We used the time elapsed between the PAD diagnosis and
the occurrence of MACE and AMI to obtain event-free
survival curves using the Kaplan-Meier method. We
compared the survival curves in relation to the ABI risk
using the Log-Rank test.
& RESULTS
There were no significant hematomas or systemic
complications after cardiac catheterization that would have
interfered with the ABI measurements. In our sample
(n = 100) there was a predominance of women (57%) and
the average age was 77.4 years old (SD 6.7 years), ranging
from 65 to 93 years, and the risk factor with the highest
prevalence was hypertension (96%). The medium value for
the ABI was 0.88 (SD 0.26), and we diagnosed PAD in 47%
of the patients. The demographic characteristics of the
population studied are presented in Table 1. The mean
systolic blood pressure in the PAD group was higher than in
the group without PAD (p,0.001), and after applying two
correlation coefficients, we noted a significant negative
correlation between systolic blood pressure and ABI,0.9,
which is expected because the calculation of ABI is always
inversely proportional to the systolic blood pressure. The
prevalence of hypertension was high in both groups, among
both patients with PAD (100%) and those with a normal ABI
(94.3%). The drugs that were used in this study are shown in
Table 1. There was a higher proportion of patients without
PAD using calcium blockers (32.2% and 13.3%, p= 0.024);
Acetylsalicilic acid was the most frequently prescribed
medication in both groups, followed by statins, beta
blockers, ACE inhibitors, diuretics, oral hypoglycemics,
ARBs, insulin, fibrates and antiplatelet agents, with no
difference between groups with PAD and without PAD.
Chronic renal failure, defined by a plasma creatinine level
greater than 2.0, was not associated with reduced ABI, as
shown in Table 1.
The extent of CADwas evaluated according the number of
coronary arteries involved and revealed a high prevalence of
multiarterial patients in the PAD group compared to
uniarterial patients of the same group. However, there was
a high prevalence of uniarterial patients without PAD
(Table 1). Thus, we observed that the more severe the CAD,
the lower the ABI with higher PAD prevalence. In fact, in
multiarterial patients, the ABI medium value was signifi-
cantly lower compared to uniarterial patients. (0.8¡0.2 and
1.0¡0.3, respectively, p=0.047).
Data analysis indicated that the presence of multiarterial
coronary disease is a risk factor for PAD development, with
a two-fold increase (RR= 2.19, CI 95%=1.27–3.77).
Over a mean period of 28.9 months (SD 6.6 months), we
performed late follow-up assessments on all of the 100
patients who were part of the trial since the trial began.
There were 17 major events with 11 deaths (11%), 9 by
cardiovascular causes (8 by acute myocardial infarction
[AMI], 1 by myocardial revascularization surgery complica-
tion), 1 by acute cholecystitis (sepsis) and 1 patient by an
undetermined cause. Most deaths occurred in the PAD
group. AMI was the main cause of death and was more
frequent among patients with PAD, as demonstrated in
Table 1.
The average annual event rate was greater than 10%.
Mortality in the PAD group was higher for both overall and
cardiovascular causes. There was also a higher incidence of
stroke in this group (6%) compared to the normal ABI
group, where there was no stroke. For non-fatal events,
there was no significant difference between patients with or
without PAD. However, MACE incidence was higher in
PAD patients (Table 1).
An ABI,0.9 was the most important factor for all-cause
mortality with a three-fold increased risk (RR 3.01; CI 95%
0.91–9.55). Additionally, a low ABI was a strong predictor
for AMI and MACE, as shown in Table 2. Even correcting
for the statistically significant difference between normal
versus low ABI and the presence of multivessel coronary
disease, the relationship between ABI and MACE remained.
Thus, adjusting the analysis for single-vessel or multivessel
disease did not significantly modify the RR (original RR 2.71
[95% CI 1.03 to 7.12] and corrected RR 2.90 [95% CI 1.11 to
7.62], as shown in Table 4).
An event-free survival curve analysis (MACE and AMI –
Figures 1 and 2, respectively) indicated that the time elapsed
between PAD diagnosis and the occurrence of MACE and
AMI was shorter in the PAD group, as shown in Table 3.
& DISCUSSION
In this study, which involved elderly patients consecu-
tively selected accordingly to coronary cineangiography and
with obstructive lesions greater than 70% in at least one
epicardial vessel, we found that 47% of these patients had
low ABIs. Similarly, a high prevalence of PAD measured by
the ABI has been reported in studies focusing on both
populations at high risk for PAD and primary care patients.
Poredos and Jug (14) correlated 42% of PAD prevalence in
elderly patients (with an average age of 63.7 years) with
CAD or cerebrovascular disease. In a study regarding acute
coronary syndrome, Nun˜ez et al. (5) reported that approxi-
mately 40% of the studied subjects (with an average age of
67.7 years) had an ABI#0.9. The high average age of the
patients included in our study (77.4 years) was higher than
the described series and may partially explain the high
prevalence of PAD we detected using the ABI, as this is a
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well-known correlation both in the general population and
in patients with documented PAD (2,3,5,20).
Major cardiovascular risk factors for CAD are usually the
same for PAD. Nonetheless, some authors suggest that there
are more specific strong risk factors associated with
atherosclerosis in certain vascular beds, such as smoking
and PAD, hypertension and cerebrovascular disease as well
as dyslipidemia associated with PAD (14). In our study,
there was no difference between the prevalence of risk
factors in PAD patients and patients with CAD only
(Table 1). This observation could be partially explained by
the fact that we studied a group of patients with a high risk
for cardiovascular events. Additionally, at the time of
inclusion, all patients were adequately medicated, and any
risk factors, such as smoking, were well controlled. As such,
only 20% of the patients were smokers at the beginning of
our study.
The evaluation of coronary cineangiography data from
this study indicated that patients with a low ABI (,0.9)
have a higher prevalence of multiarterial coronary disease
compared to uniarterial patients. Additionally, an ABI,0.9
was independently related to the extent of CAD, as
measured by the number of coronary arteries with
obstructive CAD that were detected in the coronary
angiography. Similarly, Sukhija et al. (7,16) analyzed
patients with an average age of 71 years who were
submitted to coronary angiography for suspicion of CAD
and evaluated them for PAD using the ABI. Following their
Table 1 - Demographic and angiographic characteristics and the incidence of cardiovascular events in patients with and
without PAD.
PAD (ABI,0.9) No PAD p-value
Variables (n = 47) (n = 53)
Age, years (mean ¡ standard deviation) 77.8¡6.6 77.1¡8.1 0.524
Blood pressure, mmHg (mean ¡ standard deviation)
Systolic blood pressure 158.34¡18.75 143.96¡20.45 ,0.001
Diastolic blood pressure 83.40¡7.15 83.00¡5.66 0.753
Women, n (%) 29 (61.7%) 28 (52.8%) 0.371
Men, n (%) 18 (38.3%) 25 (47.2%)
Hypertension, n (%) 47 (100%) 50 (94.3%) 0.245
Diabetes Mellitus, n (%) 20 (37.7%) 19 (40.4%) 0.783
Smoking (current or former) n (%) 15 (31.9%) 15 (28.3%) 0.694
Chronic Renal failure (Creatinine . 2.0) 6 (12.8%) 5 (9.4%) 0.595
CAD extent – uniarterial, n (%) 8 (17%) 23 (43.4%) 0.004
CAD extent – multiarterial, n (%) 39 (83.0%) 30 (56.6%)
Drugs n (%) Nitrate 17 (32.1%) 16 (34.1%) 0.835
Calcium antagonists 7 (13.3%) 15 (32.2%) 0.024
Statins 44 (83.1%) 44 (93.7%) 0.104
Beta-blockers 44 (83.1%) 35 (74.5%) 0.295
Angiotensin (IECA) 37 (69.9%) 32 (68.1%) 0.852
Diuretics 29 (54.8%) 32 (68.1%) 0.171
Acetylsalicylic acid 49 (92.5%) 44 (93.7%) 1.000
Oral hypoglycemic 11 (20.8%) 11 (23.5%) 0.750
Insulin 4 (7.6%) 6 (12.8%) 0.509
ARBs 8 (15.1%) 11 (23.5%) 0.290
Fibrates 2 (3.8%) 3 (6.4%) 0.664
Antiplatelets 2 (3.8%) 3 (6.4%) 0.664
Death, n (%) 8 (17%) 3 (5.7%) 0.070
Acute myocardial infarction, n (%) 9 (19.1%) 4 (7.5%) 0.085
Stroke, n (%) 3 (6.4%) 0 0.100
MACE n (%) 12 (25.5%) 5 (9.43%) 0.032
Age (mean¡ standard deviation) of patients with or without Peripheral Arterial Disease of the lower limbs (PAD). Major cardiovascular events (MACE);
Coronary Arterial Disease (CAD). Student’s t-test was used for the variable age (years). The chi-square test was used for the variables gender, diabetes
mellitus, smoking, CAD extent (uniarterial or multiarterial), death, acute myocardial infarction, stroke and MACE. The Fisher test was used to analyze
hypertension. The chi-square test was used to analyze chronic renal failure. Drugs were analyzed by the chi-square test or Fisher’s exact test. Student’s t-
test was used to analyze blood pressure.
Table 2 - Analysis of the incidence of death, fatal and
non-fatal acute myocardial infarction and major
cardiovascular events related to cardiovascular risk
factors and the presence of peripheral arterial disease
(PAD) evaluated by the ankle-brachial index.
RR CI 95% p-value
Death
PAD (ABI,0.9) 3.01 0.91–9.55 0.070
Gender (female) 1.32 0.41–4.22 0.637
Diabetes mellitus 1.30 0.43–3.98 0.642
Smoking 1.33 0.42–4.26 0.625
Fatal and non-fatal AMI
PAD (ABI,0.9) 2.54 0.87–7.36 0.085
Gender (female) 1.21 0.42–3.44 0.723
Diabetes mellitus 1.34 0.48–3.71 0.571
Smoking 1.46 0.51–4.13 0.475
MACE
PAD (ABI,0.9) 2.70 1.08–6.77 0.032
Gender (female) 1.38 0.55–3.43 0.481
Diabetes mellitus 1.09 0.45–2.65 0.840
Smoking 1.27 0.51–3.16 0.601
Relative risk values (RR), confidence interval (CI) and p-value. The chi-
square test was used for the variables gender, diabetes mellitus and
smoking. The presence of Peripheral Arterial Disease (PAD) was
considered to have an ankle-brachial index of ,0.9. Bivariate analysis was
performed using the chi-square test or Fisher’s exact test to evaluate
possible ABI predictors.
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analysis, they reported a high prevalence of multiarterial
patients (63%) in the PAD group and 11% of multiarterial
patients without PAD (p,0.001). Among patients in this
same population, it was noted that the lower the ABI
measurements, the higher the prevalence of multiarterial
and the lower the prevalence of uniarterial patients (84%
and 5%, respectively, p,0.001).
Papamichael et al. (15), in a study on asymptomatic PAD
patients, with an average age of 60 years, evaluated by ABI
and submitted to elective coronary angiography demon-
strated that a low ABI (#0.9) was related to a greater
extension of CAD, evaluated according to the number of
coronary arteries with obstructive CAD (variance analysis,
p=0.04) and to the Gensini score (p= 0.01).
A late follow-up analysis in our study revealed that only a
low ABI (,0.9) was a strong predictor of all-cause death
(RR 3.01; CI 95%=0.91–9.95), AMI occurrence (RR 2.54;
CI95%=0.87–7.36) and MACE incidence (2.70; CI
95%=1.08–6.77) when evaluated in relation to other risk
factors.
In fact, Criqui et al. (17) demonstrated, for the first time, a
six-fold increase in CAD mortality in elderly patients (with
an average age of 66 years) with reduced ABI compared to
patients with normal ABI. Subsequently, Newman et al. (18)
also demonstrated an up to three-fold increase in CAD
mortality in elderly individuals (with an average age of
77 years) with reduced ABI. Similarly, data from ‘‘The
Cardiovascular Health Study’’ (19), which involved 5,888
patients at over 65 years of age, demonstrated that, after a
six-year follow up, patients with a low ABI and prevalent
cardiovascular disease exhibited a 50% increase in all-cause
mortality and up to a 61% increase in fatal and non-fatal
AMI when gender and age were adjusted.
Papamichael et al. also evaluated the ABI as a prognostic
factor in elderly patients who were submitted to elective
coronary angiography and diagnosed with extracoronary
atherosclerosis (carotid and/or femoral) (15); they con-
cluded that an ABI#0.9 was the only predictor of major
cardiovascular events and revascularization procedures
when adjusted for age, LDL and cholesterol levels,
intimal-medial thickness and CAD extent.
Diehn et al. (20) concluded that symptomatic or asympto-
matic PAD (ABI#0.9) has been independently and signifi-
cantly associated with mortality and major cardiovascular
events, with an up to two-fold increase in their occurrences
compared to elderly patients without PAD in primary care
centers in Germany. Although we studied a group of
patients with a high risk for cardiovascular events, that is,
elderly patients with documented CAD, our conclusions
were similar to those from the patients in primary care
centers described in previous studies.
In our study, during late follow-up visits, we detected the
presence of stroke in patients with low ABIs (6%); this
pathology did not occur in patients with normal ABI.
Murabito et al. (21) evaluated patients from the Framingham
study, with an average age of 80 years, who were tested for
PAD by ABI; most were asymptomatic for the condition (82%).
In these patients, the authors also observed a higher prevalence
of stroke among persons with PAD compared to patients with
normal ABI (13% and 5%, respectively), with a two-fold
increased risk of stroke or transitory ischemic stroke compared
to patients with normal ABI. In fact, elderly population-based
studies revealed a positive correlation between reduced ABI
and the presence of carotid atherosclerosis (carotid stenosis or
medio-intimal thickness increase) in addition to an increased
stiffness of the aorta and the carotid arteries, a common
condition in elderly patients with PAD (22).
This study had a few limitations, including the sample size
and follow-up time. Although 100 elderly patients with PAD
diagnosed by ABI and submitted to coronary angiography
could not be regarded as a small casuistic, this sample size
was not sufficient for more conclusive associations. In fact,
the inclusion of patients after catheterizationmay have been a
limiting factor for the evaluation of patients and may
therefore have influenced the results. Furthermore, our
follow-up time could have been longer; an increased
follow-up time would contribute to an increased number of
events and would strengthen our conclusions. However, we
have not lost any patients to follow-up since their consecutive
inclusion, which strengthens our sample power; additionally,
we had more events than initially considered. Finally, the
finding of an RR of 3.01 regarding the risk related to a low
ABI was similar to findings reported in the literature, even
though our starting point for patient selection was consider-
ably different from previous studies.
In elderly patients with asymptomatic PAD and with
documented CAD by coronary cineangiography, an
ABI,0.9 proved to be a predictor of global and vascular
mortality, fatal and non-fatal AMI and stroke, with an up to
Table 4 - MACE analysis adjusting for confounding factors (ABI and multiarterial coronary disease).
Variable Crude Analysis Multivariate Analysis
RR CI (95%) p-value RR CI (95%) p-value
Multiarterial 1.078 (0.416 2.797) 0.877 0.775 0.302 1.983 0.594
ABI 2.706 1.029 7.115 0.043 2.90 1.11 7.62 0.030
Relative risk values (RR), confidence interval (CI) and p-value. The confounding effect was assessed by regression models considering the Poisson
distribution and Robust estimation, considering the RR (relative risk) given the study design. The p-value was estimated using the Poisson regression
model.
Table 3 - Time elapsed between the PAD diagnosis and
the occurrence of major cardiovascular events (MACE)
and acute myocardial infarction (AMI).
Time (years) CI 95% p-value
MACE
ABI$0.9 3.05 (2.94–3.16) 0.022
ABI,0.9 2.73 (2.51–2.94)
AMI
ABI$0.9 3.07 (2.97–3.17) 0.082
ABI,0.9 2.83 (2.63–3.03)
Time (average, years); Major cardiovascular events (MACE); Ankle-brachial
index (ABI); Confidence interval (CI); Acute myocardial infarction (AMI).
Average time was estimated by the Kaplan-Meier method. The p-value
was calculated by the Log-Rank test.
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three-fold increase compared to individuals without PAD.
We also demonstrated that, in this cohort of patients, the
lower the ABI value, the more extensive the CAD.
Therefore, ABI could be a useful tool not only for early
detection of PAD, a condition frequently underdiagnosed
on several levels of elderly care but also for the purpose of
risk stratification among CAD patients. Those patients with
reduced ABIs should undergo more aggressive cardiovas-
cular management because these patients are part of a high-
risk group for cardiovascular events and all-cause mortality.
Figure 2 - Event-free survival by ABI categories. Kaplan-Meier estimates showing AMI during the follow-up visit.
Figure 1 - Event-free survival by ABI categories. Kaplan-Meier estimates showing MACE during the follow-up visit.
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